Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Phase II Trial Assessing the Efficacy of Rituximab in HIV Infected Patients With Multicentric Castleman Disease Dependent on Chemotherapy (ANRS 117 Study, CastlemaB)

NCT00127569 is registered in ClinicalTrials.gov with French National Agency for Research on AIDS and Viral Hepatitis as lead sponsor.

NCT NCT00127569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00127569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Phase II Trial Assessing the Efficacy of Rituximab in HIV Infected Patients With Multicentric Castleman Disease Dependent on Chemotherapy (ANRS 117 Study, CastlemaB)
Lead sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2003
Completion date
January 31, 2006
Enrollment
25
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

giant lymph node hyperplasia, hiv infections